Men's Health

Top Story

Patients perceived as younger, more successful after undergoing facial rejuvenation surgery

May 16, 2017

Patients who underwent face-lift and upper facial rejuvenation surgery were perceived as younger, more attractive and more successful by observers, according to survey results recently published in JAMA Facial Plastic Surgery.

Researchers conducted web-based surveys featuring photographs of patients before and after facial rejuvenation surgery. There were 504 participants (333 women; mean age, 29 years) who successfully completed the survey.

Meeting NewsPerspective

BRCA mutations may increase risk for prostate cancer

May 15, 2017
Prostate cancer rates appeared significantly higher among men who harbored BRCA1 and BRCA2 mutations than the general public, according to results of a prospective…
Meeting NewsPerspective

Active surveillance ‘reasonable’ for younger men with low-risk prostate cancer

May 12, 2017
Active surveillance for low-risk prostate cancer may be a reasonable option among carefully selected men aged younger than 60 years, according to data presented at the…
In the Journals Plus

Molecular subtyping may predict which prostate cancers benefit from androgen deprivation therapy

May 11, 2017
The identification of prostate cancer subtypes based on luminal and basal lineage may provide a clinical tool to personalize androgen deprivation therapy use after…
In the Journals

Patients perceived as younger, more successful after undergoing facial rejuvenation surgery

May 16, 2017
Patients who underwent face-lift and upper facial rejuvenation surgery were perceived as younger, more attractive and more successful by observers…

Meeting NewsPerspective

BRCA mutations may increase risk for prostate cancer

May 15, 2017
Prostate cancer rates appeared significantly higher among men who harbored BRCA1 and BRCA2 mutations than the general public, according to results…

Meeting NewsPerspective

Active surveillance ‘reasonable’ for younger men with low-risk prostate cancer

May 12, 2017
Active surveillance for low-risk prostate cancer may be a reasonable option among carefully selected men aged younger than 60 years, according to…

In the Journals Plus

Molecular subtyping may predict which prostate cancers benefit from androgen deprivation therapy

May 11, 2017
The identification of prostate cancer subtypes based on luminal and basal lineage may provide a clinical tool to personalize androgen deprivation…

Meeting NewsPerspective

Men may require more frequent lung cancer screenings

May 11, 2017
Women may go longer between lung cancer screenings than men, according to study results presented at the European Lung Cancer Conference. The U.S…

Meeting News

Testosterone replacement therapy lowers mortality, CV risk in secondary hypogonadism

May 6, 2017
AUSTIN, Texas — Testosterone replacement therapy may lower the risk for myocardial infarction, stroke and all-cause mortality in men with…

Meeting NewsVideo

VIDEO: Pembrolizumab improves overall survival in nonsmall cell lung cancer

May 5, 2017
SAN DIEGO — Patients with PD-1 positive nonsmall cell lung cancer who were treated with pembrolizumab had improved overall survival and…

In the Journals Plus

Decipher test predicts metastasis risk following radical prostatectomy

May 4, 2017
The genomic classifier test Decipher independently improved prognostication over clinicopathologic variables for patients following a radical…

In the Journals Plus

Active surveillance of prostate cancer associated with favorable outcomes in younger men

May 1, 2017
Younger age was associated with lower risks for disease progression and biopsy-based Gleason score upgrades during active surveillance of low- or…

In the Journals

Botulinum toxin A shows efficacy in treating upper platysma area of lower face

April 27, 2017
Botulinum toxin A was effective at treating the upper platysma muscle area, showing that the area of the lower face can be safely modulated by…

More Headlines »
Advertisement
Advertisement